Some sources are clearly better than others - LOL!
Mine look to be coming up trumps:-
Knackers - 2 Dec'06 - 17:33 - 13778 of 15568 edit
QPR: Very interesting, thank you.
In my update earlier in the week on DD progress and deal status for the 4 parties interested in TroVax, there were a couple of other OXB developments/comments I also received but omitted as they didn't relate to TroVax.
1. The first was ProSavin; apparently the regulators have asked OXB to jump through a couple more hoops before it can enter the clinic (looking more like May-time) rather than 'Q1', and
2. the second was LentiVector, my source decribed this as "the one everyone has missed". Those words resonate given the Immstat update in the FT yesterday. Look out for some interesting news there.
Then we have the Wyeth development, Transgenic hens, MetXia...and the rest of the neurology pipeline etc
Knackers - 2 Dec'06 - 17:36 - 13779 of 15568 edit
Marwalker, true but I think a takeover at this stage is v unlikely. However, about a month into the ProSavin trial next year...we'll have to think again about that. OXB will be swallowed whole.